Explore the words cloud of the LIVELMIA project. It provides you a very rough idea of what is the project "LIVELMIA" about.
The following table provides information about the project.
|Coordinator Country||Italy [IT]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
|Duration (year-month-day)||from 2019-09-01 to 2020-02-29|
Take a look of project's partnership.
MicroRNAs (miRNAs) are a class of newly discovered biomolecules implicated in numerous biological systems and in common human diseases (e.g. cancer, Alzheimer, osteoarthritis). It has been shown that MiRNAs are biomarkers with great diagnostic and prognostic value. MiRNAs can be the next generation targets for diagnostics and therapeutics and this is reflected in the miRNA analysis market which is forecasted to have a CAGR of 23.4% in the coming years. Unfortunately, miRNAs are very difficult to detect and measure. The methods we have today are complex, expensive and time consuming. These limitations are restricting the use of miRNA in clinics and hospitals for diagnostic medicine. LIVELMIA is an answer to these problems. We has succeeded in developing a disruptive innovative method for high-throughput miRNAs analyses, that allows a general improvement in terms of cost, easy-of-use and accuracy. We have cut down the time required by nearly a factor of 2, bringing the total analysis time down from 6 hours to 3 hours. Furthermore LIVELMIA has a high specificity making it ideal in diagnostics to ensure quality readings in any condition. LIVELMIA is a chemical assay kit for quantification of miRNAs on various types of samples (blood, biopsies, cells) with applications in the field of health research and diagnostics medicine. Our ultimate goal is helping biomedical researchers to improve miRNA studies and move miRNA analysis from laboratory to the clinic to bring profound benefits to public health. Today we have a TRL6/7 prototype. We are gaining considerable interest from potential customers, dealers and stakeholders. We have filed for a patent in 2018 and we are now submitting this Phase 1 proposal in order to study the feasibility and develop a business plan for LIVELMIA, where we intend to study the best segments for exploitation, our pricing strategy, costs, etc.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIVELMIA" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "LIVELMIA" are provided by the European Opendata Portal: CORDIS opendata.
Polymer Biotechnological MetallizationRead More
Thermo-adjustable endoscope heater system to solve problems of fogging during surgical interventionsRead More
Dramatic hardware and energy savings in computer servers by doubling memory capacity and bandwidth using novel general-purpose compressionRead More